Pavinetant

CAS No.

941690-55-7

MDL No.

MFCD18782739

C₂₆H₂₅N₃O₃S

459.60

InChI Key

QYTBBBAHNIWFOD-NRFANRHFSA-N

Pack Size	Purity	Price	Availability
100 mg	98%	$563	In Stock
250 mg	98%	$936	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

100 mg

98%

$563

In Stock

250 mg

98%

$936

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

Pavinetant is a quinoline derivative formed by the amide condensation of the carboxy group of 3-[(methanesulfonyl)amino]-2-phenylquinoline-4-carboxylic acid with the amino group of (1S)-1-phenylpropan-1-amine. It is a neurokinin-3 receptor antagonist and antipsychotic agent, investigated for treating schizophrenia and menopausal symptoms. It belongs to quinolines, secondary carboxamides, sulfonamides, and aromatic amides.

CAS No.	941690-55-7
Product Name	Pavinetant

Biological Targets

TACR3

Associated Conditions

schizophrenia·Flushing·polycystic ovary syndrome

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Pavinetant

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.

Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial.

The selective neurokinin 3 antagonist AZD2624 does not improve symptoms or cognition in schizophrenia: a proof-of-principle study.

Identification of the covalently bound flavin of L-gulono-gamma-lactone oxidase.

Documentation